Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure: Rationale and design of CONNECT-HF.

[1]  J. H. Patterson,et al.  Titration of Medical Therapy for Heart Failure With Reduced Ejection Fraction. , 2019, Journal of the American College of Cardiology.

[2]  Mahesh J. Patel,et al.  Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction. , 2019, Journal of the American College of Cardiology.

[3]  R. Haynes,et al.  Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial , 2019, JAMA.

[4]  S. Haneuse,et al.  Association of the Hospital Readmissions Reduction Program With Mortality Among Medicare Beneficiaries Hospitalized for Heart Failure, Acute Myocardial Infarction, and Pneumonia , 2018, JAMA.

[5]  Deepak L. Bhatt,et al.  Trends in Hospice Discharge and Relative Outcomes Among Medicare Patients in the Get With The Guidelines–Heart Failure Registry , 2018, JAMA cardiology.

[6]  S. Solomon,et al.  Vaccination Trends in Patients With Heart Failure: Insights From Get With The Guidelines-Heart Failure. , 2018, JACC. Heart failure.

[7]  J. H. Patterson,et al.  Medical Therapy for Heart Failure With Reduced Ejection Fraction: The CHAMP-HF Registry. , 2018, Journal of the American College of Cardiology.

[8]  Karen E. Joynt Maddox,et al.  US National Trends in Mortality From Acute Myocardial Infarction and Heart Failure: Policy Success or Failure? , 2018, JAMA cardiology.

[9]  S. Connolly,et al.  Knowledge to action: Rationale and design of the Patient‐Centered Care Transitions in Heart Failure (PACT‐HF) stepped wedge cluster randomized trial , 2017, American heart journal.

[10]  Roland A Matsouaka,et al.  Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.

[11]  Deepak L. Bhatt,et al.  Association of the Hospital Readmissions Reduction Program Implementation With Readmission and Mortality Outcomes in Heart Failure , 2017, JAMA cardiology.

[12]  Mircea Cinteza,et al.  A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial , 2017, The Lancet.

[13]  C. Yancy,et al.  The Hospital Readmission Reduction Program Is Associated With Fewer Readmissions, More Deaths: Time to Reconsider. , 2017, Journal of the American College of Cardiology.

[14]  R. Sacco,et al.  ACC/AHA Special Report: Clinical Practice Guideline Implementation Strategies: A Summary of Systematic Reviews by the NHLBI Implementation Science Work Group: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.

[15]  S. Solomon,et al.  Potential Mortality Reduction With Optimal Implementation of Angiotensin Receptor Neprilysin Inhibitor Therapy in Heart Failure. , 2016, JAMA cardiology.

[16]  Adrian F Hernandez,et al.  Trends in 30-Day Readmission Rates for Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Registry. , 2016, Circulation. Heart failure.

[17]  C. Yancy,et al.  Cluster-Randomized Trial of Personalized Site Performance Feedback in Get With The Guidelines-Heart Failure , 2015, Circulation. Cardiovascular quality and outcomes.

[18]  Eric E. Smith,et al.  Synthesizing Lessons Learned From Get With The Guidelines: The Value of Disease-Based Registries in Improving Quality and Outcomes , 2013, Circulation.

[19]  Harlan M. Krumholz,et al.  Hospital Strategies Associated With 30-Day Readmission Rates for Patients With Heart Failure , 2013, Circulation. Cardiovascular quality and outcomes.

[20]  C. Yancy,et al.  Get With The Guidelines Program Participation, Process of Care, and Outcome for Medicare Patients Hospitalized With Heart Failure , 2012, Circulation. Cardiovascular quality and outcomes.

[21]  C. Yancy,et al.  Potential impact of optimal implementation of evidence-based heart failure therapies on mortality. , 2011, American heart journal.

[22]  C. Yancy,et al.  Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. , 2010, JAMA.

[23]  C. Yancy,et al.  Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. , 2007, JAMA.

[24]  Nancy M Albert,et al.  Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. , 2007, Journal of the American College of Cardiology.

[25]  C. O'connor,et al.  Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry. , 2007, American heart journal.

[26]  D. Ashby,et al.  Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. , 2006, International journal of epidemiology.

[27]  C. O'connor,et al.  Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design. , 2004, American heart journal.

[28]  G. Fonarow,et al.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. , 2017, Circulation.